2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with Germinoblastoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adamson, RH; Kristiansen, E; Mortensen, A; Sørensen, IK; Thorgeirsson, SS; van Kreijl, C | 2 |
2 other study(ies) available for 2-amino-3-methylimidazo(4,5-f)quinoline and Germinoblastoma
Article | Year |
---|---|
Short-term carcinogenicity testing of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in E(mu)-pim-1 transgenic mice.
Topics: Animals; Carcinogenicity Tests; Carcinogens; Dose-Response Relationship, Drug; Enhancer Elements, Genetic; Female; Imidazoles; Lymphocytes; Lymphoma; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-pim-1; Quinolines; Sex Factors; Time Factors | 1996 |
Lymphoma induction by heterocyclic amines in E mu-pim-1 transgenic mice.
Topics: Animals; Carcinogens; Female; Imidazoles; Lymphoma; Male; Mice; Mice, Transgenic; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-pim-1; Quinolines; Sex Factors | 1997 |